(RTTNews) - PTC Therapeutics, Inc. (PTCT), a biopharmaceutical company, said Tuesday that its Board of Directors has authorized a share repurchase program of up to $500 million.
我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。
Veytics Intelligence
PTC Therapeutics Board Approves $500 Mln Share Buyback
